Related Experiment Video
Updated: Mar 26, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Diagnosis of giant cell arteritis: when should we biopsy the temporal artery?
Omar Hussain1, Andrew McKay2, Kevin Fairburn3
1Oral and Maxillofacial Department, Doncaster and Bassetlaw Foundation Trust.
Insights
Giant cell arteritis (GCA) diagnosis can be improved by using the American College of Rheumatology (ACR) classification. This study found that clinical diagnosis via ACR criteria often precedes temporal artery biopsy confirmation, suggesting optimized referral criteria.
Area of Science:
- Rheumatology
- Pathology
- Surgical Oncology
Background:
- Giant cell arteritis (GCA) is a vasculitis diagnosed via temporal artery biopsy and clinical assessment using the American College of Rheumatology (ACR) 5-point score.
- The current diagnostic pathway may lead to unnecessary biopsies, impacting patient care and resource allocation.
Purpose of the Study:
- To evaluate the diagnostic utility of the ACR classification in identifying GCA in patients referred for temporal artery biopsy.
- To determine if clinical diagnosis based on ACR criteria can reliably predict histopathological findings, thereby reducing unnecessary referrals.
Main Methods:
- A retrospective audit of 100 patient referrals for temporal artery biopsy was conducted over 34 months.
- Patients were assessed using the 1990 ACR classification criteria to determine clinical GCA diagnosis at referral.
- Referral data and biopsy results were compared to calculate diagnostic accuracy metrics.
Main Results:
- Of 98 patients who underwent biopsy, 15 were diagnosed with GCA. Thirteen of these had a prior clinical diagnosis based on ACR criteria.
- The ACR classification demonstrated high specificity (96%) but low sensitivity (20%) for diagnosing GCA.
- A linear correlation was observed between higher ACR scores and histopathological confirmation of GCA.
Conclusions:
- Temporal artery biopsy for GCA is most beneficial in cases of diagnostic uncertainty (ACR score 1 or 2), atypical presentations, or when steroid contraindications exist.
- The ACR classification is a valuable tool for refining GCA diagnosis and optimizing referral for temporal artery biopsy.
- A new referral form based on ACR criteria was designed to improve patient selection for biopsy.
Abstract:
Giant cell arteritis (GCA) can be diagnosed histopathologically by biopsy of the temporal artery, and clinically using the 5-point score of the 1990 American College of Rheumatology (ACR) classification. We aimed to find out whether some patients are referred for biopsy unnecessarily. We audited all referrals (n=100) made to the Department of Oral and Maxillofacial Surgery over 34 months, and used the ACR classification to find out whether patients had had a clinical diagnosis of GCA at referral (ACR score: 3 or more). We then compared them with the result of the biopsy. Of the 100 referred, 98 had a biopsy, and of them, 15 were diagnosed with GCA (2 results were not included). Thirteen of the 15 had already been diagnosed clinically (based on the ACR classification) at referral. Our results gave an ACR specificity of 96% (95% CI: 85% to 99%) but only 20% sensitivity (95% CI: 11% to 32%). There was a linear correlation of high ACR scores with histopathological confirmation. Biopsy is most beneficial when there is a degree of diagnostic uncertainty (ACR: 1 or 2), an atypical presentation, or when steroids may be relatively contraindicated. On the basis of our study, we designed a new referral form for biopsy based on the ACR criteria.
More Related Videos
Related Concept Videos
Assessing Body Temperature - Temporal Artery
Step 1: Perform hand hygiene and don a fresh pair of gloves to prevent cross-infection and ensure patient safety.
Step 2: Explain the procedure to the patient to establish trust. Clear communication establishes trust with the patient, ensures they understand what to expect, promotes cooperation, and enhances comfort during the procedure.
Step 3: Assess the patient's...
Myocarditis II: Clinical Features and Diagnostic Tests
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Aneurysm II: Clinical Manifestations and Diagnostic Studies

